Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Gunshots were reported inside the Philippine Senate as people were instructed to take cover, witnesses said, amid mounting tension over a move to arrest Senator Ronald dela Rosa following the International Criminal Court's unsealing of an arrest warrant. Troops in camouflage, some armed with assault rifles, were seen at the building while dela Rosa…
UBS analysts report that global crude inventories have fallen sharply since February and may reach record lows by the end of May. Temporary cushions - including demand destruction, strategic reserve releases and transit waivers for Iranian and Russian cargoes - have delayed the descent, but those offsets are fading. The bank flags heightened price …
Wix.com Ltd. shares dropped sharply after the company reported fourth-quarter results that missed analyst expectations on both earnings per share and revenue. The shortfall, coupled with analyst commentary highlighting intensifying competitive headwinds and investor reluctance to underwrite long-term terminal value risk amid new product rollouts, t…
Astrotech Corporation reported its third-quarter fiscal year 2026 financial results with declining R&D expenses as it moves from development to commercialization. The company deployed its TRACER 1000 system across multiple countries and maintains a healthy sales pipeline amid disciplined cost control and strategic investments. Revenue declined comp…
On Holding (ONON) combines durable premium positioning in running and lifestyle footwear with recent margin upgrades and institutional accumulation. The stock is trading nearer its 52-week low while fundamental momentum and technical setups suggest asymmetric upside. This trade idea lays out entry, stop and targets for a long-term position over 180…
Tower Semiconductor on Wednesday updated its near-term outlook, forecasting second-quarter revenue above analyst expectations and disclosing $1.3 billion in silicon photonics agreements for 2027. The company said it has already received $290 million in advance payments to reserve production capacity and reported stronger first-quarter results that …
Candel Therapeutics, a clinical-stage biopharmaceutical company developing multimodal immunotherapies for cancer, announced that its CEO, Paul Peter Tak, will present at the Stifel 2026 Virtual Targeted Oncology Forum and the 2026 Jefferies Global Healthcare Conference. The company highlighted progress in its lead product candidates, including agla…
The Trump administration will temporarily stop new home health and hospice providers from enrolling in Medicare, citing widespread fraud risks. The nationwide moratorium, announced by a Vice Presidential anti-fraud task force, aims to give the Centers for Medicare & Medicaid Services time to account for program spending and issue new guidance. The …
Quantum Cyber N.V. has entered into an exclusive IP License Agreement with BP United Inc., securing innovative autonomous drone technology to advance its Quantum-ready defense platform. This move aligns with the Trump administration's significant $55 billion budget request for drone and autonomous warfare programs, marking a historic increase and s…
Allegro MicroSystems, a leader in power and sensing semiconductor solutions, announced its participation in TD Cowen's 54th Annual Technology, Media & Telecom Conference on May 27, 2026. The company's EVP and CFO, Derek D'Antilio, will deliver a fireside chat, further communicating Allegro's advancements and positioning in electrification, automati…
Sionna Therapeutics announced that its management will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference to discuss its development of novel medicines targeting cystic fibrosis. The company focuses on stabilizing the CFTR protein's NBD1 domain to improve treatment outcomes for CF patients, leveraging a pipe…
Century Therapeutics reported Q1 2026 financial results and updates on its induced pluripotent stem cell (iPSC)-derived therapies. The company remains on track to submit an IND for CNTY-813, a type 1 diabetes islet therapy, by Q4 2026 with initial clinical data expected in the second half of 2027. Additionally, Century plans to initiate clinical tr…
Silexion Therapeutics announced the commencement of GMP clinical batch manufacturing for SIL204, their next-generation siRNA therapy targeting mutated KRAS in locally advanced pancreatic cancer. The company also received ethics committee approval from Tel Aviv Sourasky Medical Center to conduct a Phase 2/3 clinical trial of SIL204, marking critical…
Foremost Clean Energy Ltd. announced successful completion of its 2026 drilling program at the Hatchet Lake South Uranium Project in northern Saskatchewan, expanding the Tuning Fork Uranium Zone with multiple significant uranium mineralization intercepts. The program included 19 diamond drill holes with high-grade results supporting continued explo…
One Stop Systems, Inc. (Nasdaq: OSS), a US-based leader in rugged high performance AI and machine learning compute solutions for edge applications, announced its participation in Special Operations Forces Week from May 19 to 21, 2026. The company will demonstrate its rugged AI compute products designed for defense applications, collaborating with i…
Verrica Pharmaceuticals announced that its CEO will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference held at NASDAQ, highlighting its dermatological therapeutics pipeline including FDA-approved YCANTH® for molluscum contagiosum and development programs for common warts and non-melanoma skin cancers.
Cerence Inc., a leader in conversational AI-powered automotive experiences, announced its participation in the TD Cowen 54th Annual Technology, Media & Telecom Conference. Its CEO and CFO will engage in a fireside chat and one-on-one investor meetings, highlighting company strategies and innovations in AI and automotive technology.
TTEC Digital has entered a strategic collaboration agreement with Amazon Web Services to enhance adoption of Amazon Connect by integrating AI-powered customer experience solutions, simplifying contact center modernization. This partnership aims to deliver intelligent self-service, agent assistance, and real-time data capabilities to organizations, …
Pacira BioSciences, a leader in non-opioid pain management therapies, announced its participation in analyst-led fireside chats at three major healthcare conferences in May and June 2026. The company highlighted its existing commercial products and ongoing clinical pipeline, including a gene therapy candidate in Phase 2 development for osteoarthrit…
electroCore announced new clinical findings published in JAMA Network Open demonstrating that adding the Quell electrical nerve stimulation device to outpatient physical therapy significantly reduces movement-evoked pain and fatigue in fibromyalgia patients, with benefits observed within 30 days and sustained up to six months.
Photronics, a global leader in photomask technologies, plans to report its fiscal second quarter 2026 financial results on May 28, 2026, before market open. The company will also hold a public conference call to discuss financial performance, business conditions, and industry outlook.
Abacus Global Management, a financial services company listed on the NYSE under ticker ABX, will participate in the 26th Annual B. Riley Investor Conference held May 20-21, 2026. Company executives will engage with investors to discuss their focus on alternative asset management, longevity-based assets, and personalized financial planning.
SailPoint, a leader in enterprise identity security, announced it will release its fiscal first quarter 2027 financial results on June 9, 2026, prior to the US market open. The company will host a conference call to discuss results and outlook, followed by an Investor Day event on June 16, featuring strategy, innovation, and financial presentations…
UroGen Pharma Ltd. announced positive 36-month duration of response data from its Phase 3 ENVISION trial of ZUSDURI (mitomycin) for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC). The Kaplan-Meier analysis showed 64.5% of patients achieving complete response at three months remained event-free at three years,…
INmune Bio announced it as a founding member of the American Biotech Innovation Alliance (ABIA), a coalition of biotechnology companies working to develop a national strategy to maintain and extend U.S. leadership in biotech innovation. The alliance will address key industry challenges such as manufacturing capacity, early research investment, regu…
